Britta Blaschke

2.0k total citations
15 papers, 1.5k citations indexed

About

Britta Blaschke is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Britta Blaschke has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Britta Blaschke's work include Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Britta Blaschke is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Britta Blaschke collaborates with scholars based in Germany and United Kingdom. Britta Blaschke's co-authors include Guido Reifenberger, Marietta Wolter, Christiane B. Knobbe‐Thomsen, J. Reifenberger, Thomas Ruzicka, G. Reifenberger, Ruthild G. Weber, V. Peter Collins, Guido Reifenberger and Koichi Ichimura and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Britta Blaschke

15 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britta Blaschke Germany 14 904 655 356 306 253 15 1.5k
G. Reifenberger Germany 11 1.1k 1.2× 402 0.6× 158 0.4× 243 0.8× 101 0.4× 13 1.5k
Daniel Schrimpf Germany 20 593 0.7× 1.2k 1.8× 326 0.9× 467 1.5× 399 1.6× 52 1.7k
Hilary Blair United States 12 429 0.5× 703 1.1× 122 0.3× 319 1.0× 249 1.0× 17 1.2k
Keiko Funa Sweden 20 716 0.8× 118 0.2× 356 1.0× 215 0.7× 222 0.9× 37 1.6k
David Cappellen France 21 1.6k 1.7× 182 0.3× 153 0.4× 277 0.9× 177 0.7× 50 2.3k
Steffi Urbschat Germany 18 451 0.5× 406 0.6× 305 0.9× 207 0.7× 91 0.4× 58 1.2k
Felipe Andreiuolo France 24 721 0.8× 1.2k 1.9× 301 0.8× 331 1.1× 357 1.4× 64 1.9k
Laura Morsberger United States 16 569 0.6× 241 0.4× 87 0.2× 433 1.4× 339 1.3× 43 1.3k
Damian Stichel Germany 17 339 0.4× 454 0.7× 164 0.5× 246 0.8× 275 1.1× 38 951
Robert T. Jones United States 8 513 0.6× 168 0.3× 510 1.4× 154 0.5× 128 0.5× 20 1.2k

Countries citing papers authored by Britta Blaschke

Since Specialization
Citations

This map shows the geographic impact of Britta Blaschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Blaschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Blaschke more than expected).

Fields of papers citing papers by Britta Blaschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Blaschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Blaschke. The network helps show where Britta Blaschke may publish in the future.

Co-authorship network of co-authors of Britta Blaschke

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Blaschke. A scholar is included among the top collaborators of Britta Blaschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Blaschke. Britta Blaschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tews, Björn, Peter Roerig, Christian Hartmann, et al.. (2007). Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene. 26(34). 5010–5016. 35 indexed citations
2.
Wick, Antje, Jörg Felsberg, Joachim P. Steinbach, et al.. (2007). Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma. Journal of Clinical Oncology. 25(22). 3357–3361. 198 indexed citations
3.
Weber, Ruthild G., Alexander Hoischen, Kerstin Kaulich, et al.. (2006). Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene. 26(7). 1088–1097. 76 indexed citations
5.
Herrlinger, Ulrich, Johannes Rieger, Dorothee Koch, et al.. (2006). Phase II Trial of Lomustine Plus Temozolomide Chemotherapy in Addition to Radiotherapy in Newly Diagnosed Glioblastoma: UKT-03. Journal of Clinical Oncology. 24(27). 4412–4417. 125 indexed citations
6.
Reifenberger, J., Marietta Wolter, Christiane B. Knobbe‐Thomsen, et al.. (2005). Somatic mutations in thePTCH,SMOH,SUFUHandTP53genes in sporadic basal cell carcinomas. British Journal of Dermatology. 152(1). 43–51. 299 indexed citations
7.
Reifenberger, J., et al.. (2004). Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. International Journal of Cancer. 109(3). 377–384. 103 indexed citations
8.
Felsberg, Jörg, Michael Sabel, Rolf Fimmers, et al.. (2004). Oligodendroglial Tumors: Refinement of Candidate Regions on Chromosome Arm 1p and Correlation of 1p/19q Status with Survival. Brain Pathology. 14(2). 121–130. 136 indexed citations
9.
Knobbe‐Thomsen, Christiane B., J. Reifenberger, Britta Blaschke, & G. Reifenberger. (2004). Hypermethylation and Transcriptional Downregulation of the Carboxyl-Terminal Modulator Protein Gene in Glioblastomas. JNCI Journal of the National Cancer Institute. 96(6). 483–486. 47 indexed citations
10.
Kaulich, Kerstin, Britta Blaschke, Astrid Nümann, et al.. (2002). Genetic Alterations Commonly Found in Diffusely Infiltrating Cerebral Gliomas Are Rare or Absent in Pleomorphic Xanthoastrocytomas. Journal of Neuropathology & Experimental Neurology. 61(12). 1092–1099. 41 indexed citations
11.
Reifenberger, J., Christiane B. Knobbe‐Thomsen, Marietta Wolter, et al.. (2002). Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. International Journal of Cancer. 100(5). 549–556. 90 indexed citations
12.
Wolter, Marietta, J. Reifenberger, Britta Blaschke, et al.. (2001). Oligodendroglial Tumors Frequently Demonstrate Hypermethylation of theCDKN2A(MTS1, p16INK4a),p14ARF, andCDKN2B(MTS2,p15INK4b) Tumor Suppressor Genes. Journal of Neuropathology & Experimental Neurology. 60(12). 1170–1180. 76 indexed citations
13.
Boström, Jan, Birgit Meyer‐Puttlitz, Marietta Wolter, et al.. (2001). Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic Meningiomas. American Journal Of Pathology. 159(2). 661–669. 204 indexed citations
14.
Wolter, Marietta, Britta Blaschke, Ruthild G. Weber, et al.. (2001). Analysis of human meningiomas for aberrations of theMADH2,MADH4,APM-1 andDCC tumor suppressor genes on the long arm of chromosome 18. International Journal of Cancer. 92(4). 551–554. 26 indexed citations
15.
Scharlau, Rudolf & Britta Blaschke. (1996). Reflective Integral Lattices. Journal of Algebra. 181(3). 934–961. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026